|Join Our Mailing List | Audio Packages | Contact Us | Our Homepage|
Partial List of
Thursday, May 30, 2019
8:00 am – 5:00 pm
New York City
Bass Berry & Sims PLC
INSIGHTS FROM 20 EXPERT SPEAKERS!
Until recently, consolidation has been the main driver of private equity activity in the specialty pharmacy industry. But that’s changing as more and more PE firms have gotten interested.
Here are three key characteristics of specialty pharmacies that investors are finding
Look at PANTHERx Specialty Pharmacy, which operates as an exclusive (or highly limited) marketing partner for a small number of specialty drug makers. Its unique treatments have made PANTHERx one of Inc. Magazine’s fastest growing companies for the third straight year, consistently ranking among the top 50 companies.
The firm works with prominent biotechnology partners such as Alexion, Neurocrine, Ultragenyx, Otsuka, and Insmed.
Orphan drugs have been approved at a fast clip over the last couple of years. The potential of orphan drugs is just one of several developments that are drawing PE investors to specialty pharmacies. Other developments include new gene therapies soon to be coming to market, as well as precision medicine therapies, which can have price points even greater than $1m.
Click here to receive our best rate -- a savings of $300 on our regular conference rates!
Other trends include --
You’ll gain valuable insights when you register to hear our 20+ panelists assess the outlook for investing in specialty pharmacy companies at The Capital Roundtable’s all-day conference on Thursday, May 30, 2019, in midtown New York City.
Here Are Three Key Reasons Why You Should Join Us
Of course, all subsectors aren’t equal. Some, like hospital pharmacies, are hot, while others remain out of favor. And understanding regulatory trends and drug makers’ needs is critical to determining which kinds of companies are likely to prosper.
Click Here to Register to Hear Our 20+ Speakers Address Key Points Such As --
Register Now to Enhance Your Awareness of Opportunities in This
Recent Middle-Market Specialty Pharmacy Deals
This Capital Roundtable conference is the ideal place to expand your network and open up pathways to future deals. The day’s agenda includes ample time to let you --
Keep in mind this conference is certain to fill up quickly, so you’ll want to register as soon as possible to assure yourself a seat. To avoid disappointment, please contact Chris Agar today to confirm your attendance at 212-832-7300 ext. 0 or firstname.lastname@example.org
Designed to Meet the Needs of GPs, LPs, & Managers of Buyout, Growth Equity, Mezzanine, BDC, and Lending Funds, as Well as Independent Sponsors, Operating Partners, Portfolio Company Managers, and the Bankers, Lawyers, Accountants, & Other Advisors Who Support Them.
We look forward to having you join us on Thursday, May 30, 2019.
This conference is being produced by The Capital Roundtable, America’s leading conference organization focusing on “need-to-know” information for professionals in the middle-market private equity community. For more information about The Capital Roundtable’s 30 annual conferences and other events and programs, please visit www.capitalroundtable.com.
Speaking & Business Development Opportunities
We offer excellent speaking, marketing, and business development opportunities to reach the middle‑market private equity community. For more details, please contact Kellie Green or Claire Notton at 212-832-7300 or by email at email@example.com or firstname.lastname@example.org.
Have a Question?
Please contact Melissa Layne at email@example.com or 212-832-7300 ext. 0.
Who We Are
This Capital Roundtable conference in midtown, New York City, is all-business, all-targeted, all-designed to be a completely focused day of practical information and revealing insights. You’ll gain valuable insights from --
Space at this conference is limited, so register as soon as possible to assure yourself a seat. To avoid disappointment, please contact Chris Agar today to confirm your attendance at 212-832-7300 ext. 0 or firstname.lastname@example.org.
Please note that The Capital Roundtable limits the number of registrants from a single firm to three.
You can pay by credit card (using the links above) or by check. Mail your check and business card to: New York Business Roundtable Inc., 747 Third Avenue, Suite 200, New York, NY 10017.
Have a special question? Please contact Chris Agar at email@example.com or 212-832-7300 ext. 0.
From time to time, for reasons beyond Capital Roundtable's control, program schedules and speakers become subject to change. We make every effort to announce substantive changes by email to registrants at least 48 hours in advance.
We offer excellent marketing and business development opportunities to reach the middle‑market private equity community. For more details, please contact Claire Notton at 212-832-7300 ext.117, or by email at firstname.lastname@example.org.
No part of this text may be reproduced or otherwise published without the express written consent of The Capital Roundtable.